Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 January 2001

Endothelial cell dysfunction in a model of oxidative stress.

Liming Jin, Gamal Abou-Mohamed, Ruth B Caldwell, William R Caldwell

Med Sci Monit 2001; 7(4): BR585-591 :: ID: 421099

Abstract

BACKGROUND: We have investigated the role of L-arginine in hyperhomocysteinemia(HHCY). L-arginine is the substrate required for NO production by endothelial NOS (eNOS). When L-arginineis limited, NOS acts principally upon O2 to form superoxide (O2.-). Because HHCY causes formation ofreactive oxygen species and reduced endothelial-dependent vasodilation, we hypothesized that HHCY decreasesNO formation by limiting the cellular supply of L-arginine.MATERIAL AND METHODS: Studies with culturedbovine aortic endothelial cells (ECs) determined effects of HCY on transport of [3H] L-arginine. Effectson L-arginine transporter protein CAT-1 and eNOS protein were assessed by immunoblotting. Peroxynitriteformation was evaluated by an immunoassay for nitrotyrosine levels. eNOS activity in forming NO was determinedby assay for 3H-L-arginine to 3H-citrulline conversion.RESULTS: HCY had a depressive effect on argininetransport in ECs. HCY treatment for a 24 hr period decreased arginine uptake by 27%. HCY treatment for24 hr significantly reduced cellular levels of the CAT-1 arginine transporter protein ( approximately30%) and increased nitrotyrosine formation, whereas levels of eNOS protein and basal NOS activity werenot altered. Nevertheless, total NO production as indicated by citrulline conversion was significantlydecreased. Treatment with the antioxidant N-acetylcysteine reversed the HCY effect on arginine transport,suggesting that transporter oxidation may contribute to the endothelial dysfunction.CONCLUSIONS: Theassociation of HCY-induced decreases in NO formation with decreases in function and expression of thearginine transporter in the absence of alterations in eNOS expression or activity suggests a primaryrole for arginine transport alterations in HHCY. The action of HCY to reduce arginine uptake may accentuateendothelial dysfunction due to generation of O2.- and peroxynitrite formation, which may cause furtheroxidative injury.

Keywords: Hyperhomocysteinemia, L-arginine uptake, endothelial cell dysfunction,

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

26 Feb 2024 : Clinical Research  

Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...

Med Sci Monit In Press; DOI: 10.12659/MSM.942509  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750